))
ICT Ep17: Exploring Enrollment Gaps in Oncology Trials with Selin Kurnaz (Part 2 of 3)
Manage episode 444326881 series 3578161
Conteúdo fornecido por Liam Eves and Ted Trafford, Liam Eves, and Ted Trafford. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Liam Eves and Ted Trafford, Liam Eves, and Ted Trafford ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford continue their discussion with Selin, CEO and founder of Massive Bio, an AI-powered platform that connects cancer patients with clinical trials. The conversation centers around the critical challenges in oncology trial enrollment, from recruitment failures to the operational difficulties encountered in the "Last Mile." We discuss the need for transparency, education, and a rethinking of traditional clinical trial processes. Selin discusses the complexity of site selection, prescreening, and patient identification, highlighting that the current system often overlooks the operational steps that are crucial for successful trial participation.
18 episódios
Compartilhar
